Since 2003, Monarch Medical Technologies develops technology to improve hospital glucose management and insulin dosing. Our mission is to advance clarity in healthcare by delivering safe, patient-specific insulin therapy at scale.

EndoTool is a patient-specific insulin dosing system that predicts individual responses to insulin and provides precise IV and subcutaneous dosing recommendations. It helps clinicians reduce hypoglycemia and improve glycemic outcomes across hospitals.

Monarch partners with hospitals and provides clinical evidence, case studies, analytics and implementation support. Their solutions are designed to integrate into hospital workflows and deliver measurable improvements in patient safety and cost savings.